This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (8)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal

Arch Intern Med. 2001;161:1113-1114.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Low-molecular-weight heparin (LMWH) has several advantages over conventional unfractionated heparin in the prevention and treatment of deep venous thrombosis (DVT).¹ Enoxaparin is a LMWH approved for several indications such as unstable angina, non–Q-wave myocardial infarction, and DVT.^2-3 There are reports of epidural or spinal hematomas after spinal puncture in patients being treated with enoxaparin that can result in permanent paralysis.² We describe a patient who developed a debilitating soft tissue hematoma after femoral venipunctures while being treated with enoxaparin.

Report of a Case

A 74-year-old man (weight, 80 kg) was admitted with DVT of the left popliteal vein. Treatment was started with 80 mg of enoxaparin subcutaneously twice daily. On the second day, an inferior vena caval filter was inserted through the right femoral vein because of concerns regarding his compliance. Exploration and direct visual cannulation of the right common femoral vein was performed because the initial 2 percutaneous attempts were unsuccessful. Enoxaparin administration . . . [Full Text of this Article]

Comment

RELATED LETTER

A Correct Evaluation of Renal Function Could Decrease Bleeding Risk in Anticoagulated Elderly Patients
Enrique Antón
Arch Intern Med. 2005;165(3):349-350.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Correct Evaluation of Renal Function Could Decrease Bleeding Risk in Anticoagulated Elderly Patients
Anton
Arch Intern Med 2005;165:349-350.
FULL TEXT